Image Is Everything
The division of Loders Croklaan formerly known as Loders Croklaan Lipid Nutrition has modified its name to Lipid Nutrition, a division of Loders Croklaan. Intended to emphasise the company?s primary business focus—lipid-based health ingredients—the change is accompanied by a new logo and will extend to all of the company?s marketing communication and other materials. California-based Armstrong Associates, corporate and brand images development firm, worked with Lipid Nutrition on creating the company?s ?image blueprint?. An updated Lipid Nutrition website is scheduled to launch in 2004.
Not To Be Confused With
Massachusetts-based Brunswick Laboratories LLC is acting to correct a case of mistaken identity. Brunswick Laboratories, an independent, full-service, bio-analytical laboratory in Massachusetts, has been confused with Brunswick Laboratories Inc of Illinois, a business unit of NBTY Inc, which is ceasing business. Brunswick Laboratories LLC?s CEO Jim Nichols says, ?We are open for business.?
Lallemand Expands Facilities
Institut Rosell/Lallemand has expanded its research facilities at the National Research Council of Canada Biotechnology Research Institute in Montreal. The enlarged R&D team, directed by Dr Thomas A Thompkins, will increase its focus on biochemical and microbiological characterisation of probiotic strains, metabolic products and mineral-enriched yeast.
Buckton and Bio-Dar Join Forces
Buckton Scott Nutrition, the US office of the Buckton Scott Group, headquartered in Essex, UK, has entered into a long-term agreement with Bio-Dar of Israel. Buckton has become the exclusive US distributor of Bio-Dar?s BetaCote 20VB beta-carotene. BetaCote 20VB is a synthetic form of beta-carotene beadlets that is kosher and suitable for vegetarians. The companies say they hope to capitalise on the fast-growing vegetarian sub-segment of the market.
Xylitol Grant Given
A research grant from the Biotechnology Research and Development Organization (BRDC) in Peoria, Illinois, has been granted to Chicago-based zuChem, a supplier of specialised sugars for the food and pharmaceutical industry. The grant will provide zuChem with $600,000 in research funding over three years to commercialise a fermentation approach to manufacture xylitol.
The BRDC also provided $300,000 for the USDA National Center for Agricultural Utilization Research to support a scientific collaboration with zuChem on the xylitol project. Under the agreement, zuChem will hold exclusive commercialisation rights to resultant technology.
Bolar And LaPlaca Honoured
During the Council for Responsible Nutri-tion?s (CRN) 2003 Annual Conference, Paul Bolar of Pharmavite and Joe LaPlaca of Roche Vitamins were awarded CRN (Steuben) Apples. The award is CRN?s highest, presented annually to individuals who have demonstrated long-term commitment and gone above and beyond the call of duty for CRN and the dietary supplements industry. Bolar, VP, legal and regulatory affairs for Pharmavite, is the long-time chairman of the Regulatory Affairs Committee. Bolar is also involved with the Product Stewardship Task Force. LaPlaca, senior VP of Roche Vitamins, is an active member of the Board of Directors, Executive Committee and International Trade and Market Development Committee.
GM?s Next Eco-friendly Step
Gene Kahn, who founded Cascadian Farm in 1972 and Small Planet Foods in 1997, has been appointed to the position of VP, sustainable development for General Mills. He joined General Mills in 2000 to lead the company?s organic business when they acquired Small Planet. Kahn will be responsible for leading company-wide efforts to ensure the responsible management of the natural resource base and lessening the technological and institutional impact on the environment.
With this new appointment, Kahn will be transitioning out of his current assignment as president of Small Planet Foods. Maria Morgan, a General Mills VP with more than 14 years of marketing and sales experience, will be named president.
TSI Acquires ATP Patents
Technical Sourcing International (TSI) of Montana, a developer, producer and marketer of nutraceutical ingredients, has acquired an exclusive worldwide license to an extensive portfolio of both domestic and foreign patents directed to delivery of adenosine 5?-triphosphate (ATP). Under an exclusive license agreement with Eliezer Rapaport, PhD, TSI has acquired certain rights, title and interest in, and to, six issued patents and four pending patent applications with the right to grant sublicenses for all. Rapaport has published more than 50 scientific papers and is credited with the discovery that organ, red-blood cell (total blood) and blood plasma (extracellular) pools of ATP can be expanded by systemic administration of ATP.